Friday’s Top Medical & Biotech Stocks
Submitted by BioHealth Investor Blog
by H.S. Ayoub
BioHealth Investor
Subscribe now to keep up to date on the latest news, articles and daily top stocks:
Subscribe by Email
Subscribe by Feed
Biotechnology
PROTEO INC [PTEO.OB] +93.07%
BIOSANTE PHARMA INC [BPAX] +19.39%
TRANSDEL PHARMACTL [TDLP.OB] +19.20%
HESKA CORPORATION [HSKA] +18.52%
HEMOBIOTECH INC [HMBT.OB] +18.18%
Diagnostic Substances
REMOTEMDX INC [RMDX.OB] +13.42%
RESPONSE GENETICS, I [RGDX] +8.11%
INFINITY PHARMACEUTI [INFI] +6.82%
SYNTA PHARMACEUTICAL [SNTA] +4.49%
AVALON PHARMACEUTIC [AVRX] +4.33%
Drug Delivery
DELCATH SYSTEMS INC [DCTH] +16.00%
QUIGLEY CORP THE [QGLY] +6.25%
ACURA PHARMACEUTICAL [ACUR] +5.80%
FLAMEL TECH SA ADR [FLML] +2.05%
ARADIGM CORP [ARDM.OB] +1.79%
Drug Manufacturers
VYREX CORP DE NEW [VYXC.OB] +17.65%
GAMMA PHARMACEUTICAL [GMPM.OB] +12.50%
ACCESS PHARMACEUTICL [ACCP.OB] +10.37%
SEPRACOR INC [SEPR] +5.02%
PROVECTUS PHARMA [PVCT.OB] +5.00%
Drug Related Products
XELR8 HOLDINGS, INC [BZI] +4.85%
NUTRACEUTICAL INTL [NUTR] +3.54%
ARGAN INC [AGX] +1.96%
INTEGRATED BIOPHARMA [INBP] +1.02%
AUXILIUM PHARMACEUT [AUXL] +0.88%
Generic Drugs
WATSON PHARMACEUTCLS [WPI] +0.82%
HI-TECH PHARMACAL [HITK] +0.22%
Medical Appliances & Equipment
NEWCARDIO, INC. [NWCI.OB] +23.53%
XCORPOREAL INC [XCR] +14.00%
THERAGENICS CORP [TGX] +13.90%
MB SOFTWARE CORP [MBSB.OB] +13.33%
SONIC INNOVATIONS [SNCI] +12.86%
Medical Instruments & Supplies
BIOMIMETIC THERAPEUT [BMTI] +30.00%
MEDPRO SAFETY PD [MPSP.OB] +27.72%
CPC OF AMERICA INC [CPCF.OB] +11.72%
STEN CORPORATION [STEN] +10.91%
BIOSPHERE MEDICAL [BSMD] +7.80%
Medical Laboratories & Research
RADNET INC [RDNT] +1.75%
MEDTOX SCIENTFIC INC [MTOX] +1.63%
BIO-IMAGING TECH [BITI] +0.85%
GENOPTIX, INC. [GXDX] +0.56%
QUEST DIAGNOSTC [DGX] +0.53%
- Thursday’s Top Medical & Biotech Stocks
__________________
We don't know every stock and we want to know your thoughts. Register on Biotech Stocks Blog now and get published within minutes. Before posting, it is recommended that you review our posting guidelines.
